MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Rapid eye movement(REM)"

  • 2025 International Congress

    Motor & Non-Motor Symptoms in nOH & RBD

    M. Meyers, G. Smith, K. Bigos, J. Leoutsakos (Baltimore, USA)

    Objective: To assess whether the co-occurrence of neurogenic orthostatic hypotension (nOH) and REM sleep behavior disorder (RBD) is associated with a more severe clinical presentation…
  • 2025 International Congress

    Functional Alterations in Early-Stage Parkinson’s Disease and Multiple System Atrophy with REM Sleep Behavior Disorder

    SC. Wang, Y. Xiao, YB. Hou, CY. Li, RW. Ou, JY. Lin, TM. Yang, NN. Che, QR. Jiang, XT. Zheng, JY. Liu, HF. Shang (Chengdu, Sichuan, China)

    Objective: This study investigated functional brain network alterations in early-stage Parkinson’s disease (PD) and multiple system atrophy (MSA) patients with probable rapid eye movement sleep…
  • 2025 International Congress

    Semantic Memory Deficit as a Potential Risk Factor of Dementia in Isolated Rapid Eye Movement Sleep Behavior Disorder

    C. Zigrand, M. Trepanier Maurais, R. Postuma, S. Joubert, I. Rouleau, JF. Gagnon (Montreal, Canada)

    Objective: We aimed to evaluate semantic memory (SM) performance in isolated/idiopathic rapid eye movement (REM) sleep behavior disorder (iRBD) and identify the specific profile of…
  • 2025 International Congress

    Opicapone in Parkinson’s Patients with Probable REM Sleep Behavior Disorder: Insights from the OASIS Trial

    J. Ferreira, M. Gago, R. Costa, M. Fonseca, H. Brigas, D. Magalhães, J. Holenz, C. Trenkwalder (Lisbon, Portugal)

    Objective: To evaluate opicapone’s effect on sleep disturbances, motor and non-motor symptoms and quality of life in Parkinson's disease (PD) patients with and without probable…
  • 2025 International Congress

    Clinical Progression and Genetic Pathways in Body-First and Brain-First Par-kinson’s Disease

    M. Passaretti, D. Veréb, M. Mijalkov, Y. Chang, H. Zhao, J. Sun, B. Zufiria Gerbolés, G. Volpe, N. Rivera, M. Bologna, J B. Pereira (Stockholm, Sweden)

    Objective: We aim to assess Parkinson's disease (PD) phenotypes across both prodromal and clinical PD stages, track their pathological progression in vivo and identify potential underlying…
  • 2025 International Congress

    Sleep-wake Alterations are Associated with a Decreased DTI-ALPS, a Marker of Perivascular Glymphatic Functioning, in Patients with Isolated REM Sleep Behavior Disorder

    I. Roura, J. Pardo, C. Martín-Barceló, C. Falcon, R. Sala-Llonch, C. Garcia-Vicente, N. Bargalló, M. Serradell, C. Gaig, G. Mayà, A. Montini, J. Madrir, M. Rol, A. Adan, C. Junqué, A. Iranzo, B. Segura (Barcelona, Spain)

    Objective: We aimed to explore circadian disruption in iRBD and its association with the Diffusion Tensor Imaging- ALong the Perivascular Space (DTI-ALPS) index, a proxy…
  • 2024 International Congress

    Sympathetic Nervous System Overactivity in the Pre-Motor Stage of Parkinson’s Disease: Therapeutic Implications

    M. Tagliati, M. Gregorio, H. Maghzi, G. Obialisi, E. Hogg, C. Malatt, E. Tan, M. Kelly, H. Pomeroy, R. Artal, M. Shehata, B. Renner, Z. Fan, P. Sati, G. Pagano (Los Angeles, USA)

    Objective: To investigate sympathetic nervous system (SNS) activity in idiopathic REM behavior disorder (iRBD) subjects at risk for Parkinson's disease (PD), and the effect of…
  • 2024 International Congress

    Rationale and Design of the Slowing Parkinson’s Early through Exercise Dosage – United Kingdom (Slow-SPEED-UK) Trial

    E. Mitchell (London, United Kingdom)

    Objective: Slow-SPEED-UK is a randomized controlled trial investigating the effects of an app-based exercise program on individuals at higher risk of Parkinson’s Disease (PD). Background:…
  • 2024 International Congress

    Slow-SPEED-NL: study protocol for a remote trial of exercise for Parkinson’s disease prevention

    T. Oosterhof, E. Mitchell, A. Ascherio, B. Bloem, K. van Dijk, B. Dijkstra, L. Kaufmann, R. Lathey, E. Macklin, A. Navangul, A. Pijpers, H. Rowbotham, R. Schneider, M. Schwarzschild, N. de Vries, A. Noyce, S. Darweesh (Nijmegen, Netherlands)

    Objective: To determine the feasibility and preliminary efficacy of a remote exercise intervention in prodromal Parkinson’s disease (PD). Background: Disease-slowing interventions have been ineffective in…
  • 2024 International Congress

    Cortical and Subcortical Brain Volume Changes in Idiopathic REM Sleep Disorder Subjects at Risk for Parkinson’s Disease

    M. Lima Gregorio, B. Renner, Z. Fan, E. Hogg, C. Malatt, E. Tan, M. Kelly, R. Artal, P. Sati, M. Tagliati (Los Angeles, USA)

    Objective: To quantify cortical and subcortical brain volumes using structural MRI analysis in idiopathic REM sleep behavior disorder (iRBD) subjects at risk for Parkinson`s disease…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 20
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley